Literature DB >> 27863967

Host cell restriction factors that limit transcription and replication of human papillomavirus.

Samuel S Porter1, Wesley H Stepp2, James D Stamos2, Alison A McBride3.   

Abstract

The life cycle of human papillomaviruses (HPV) is tightly regulated by the differentiation state of mucosal and cutaneous keratinocytes. To counteract viral infection, constitutively expressed cellular factors, which are defined herein as restriction factors, directly mitigate viral gene expression and replication. In turn, some HPV gene products target these restriction factors and abrogate their anti-viral effects to establish efficient gene expression and replication programs. Ironically, in certain circumstances, this delicate counterbalance between viral gene products and restriction factors facilitates persistent infection by HPVs. This review serves to recapitulate the current knowledge of nuclear restriction factors that directly affect the HPV infectious cycle. Published by Elsevier B.V.

Entities:  

Keywords:  HPV; IFI16; IFIT1; Intrinsic immunity; Restriction factor; Sp100

Mesh:

Substances:

Year:  2016        PMID: 27863967      PMCID: PMC5325803          DOI: 10.1016/j.virusres.2016.11.014

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  169 in total

1.  Interferon-beta treatment of cervical keratinocytes naturally infected with human papillomavirus 16 episomes promotes rapid reduction in episome numbers and emergence of latent integrants.

Authors:  M Trent Herdman; Mark R Pett; Ian Roberts; William O F Alazawi; Andrew E Teschendorff; Xiao-Yin Zhang; Margaret A Stanley; Nicholas Coleman
Journal:  Carcinogenesis       Date:  2006-09-14       Impact factor: 4.944

2.  Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection.

Authors:  Rebecca M Richards; Douglas R Lowy; John T Schiller; Patricia M Day
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

3.  Common properties of nuclear body protein SP100 and TIF1alpha chromatin factor: role of SUMO modification.

Authors:  J S Seeler; A Marchio; R Losson; J M Desterro; R T Hay; P Chambon; A Dejean
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

4.  High-risk human papillomaviruses repress constitutive kappa interferon transcription via E6 to prevent pathogen recognition receptor and antiviral-gene expression.

Authors:  Jeanette Reiser; José Hurst; Maike Voges; Peter Krauss; Peter Münch; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

5.  Interferon treatment of human keratinocytes harboring extrachromosomal, persistent HPV-16 plasmid genomes induces de novo viral integration.

Authors:  Michael J Lace; James R Anson; Thomas H Haugen; Jason M Dierdorff; Lubomir P Turek
Journal:  Carcinogenesis       Date:  2014-11-21       Impact factor: 4.944

6.  The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle.

Authors:  E R Flores; B L Allen-Hoffmann; D Lee; P F Lambert
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

7.  ATR kinase activity regulates the intranuclear translocation of ATR and RPA following ionizing radiation.

Authors:  Sharon M Barr; Cindy G Leung; Elbert E Chang; Karlene A Cimprich
Journal:  Curr Biol       Date:  2003-06-17       Impact factor: 10.834

8.  Human papillomavirus type 31 uses a caveolin 1- and dynamin 2-mediated entry pathway for infection of human keratinocytes.

Authors:  Jessica L Smith; Samuel K Campos; Michelle A Ozbun
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

9.  Clinical and molecular characteristics of squamous cell carcinomas from Fanconi anemia patients.

Authors:  Hester J T van Zeeburg; Peter J F Snijders; Thijs Wu; Eliane Gluckman; Jean Soulier; Jordi Surralles; Maria Castella; Jacqueline E van der Wal; Johan Wennerberg; Joseph Califano; Eunike Velleuer; Ralf Dietrich; Wolfram Ebell; Elisabeth Bloemena; Hans Joenje; C René Leemans; Ruud H Brakenhoff
Journal:  J Natl Cancer Inst       Date:  2008-11-11       Impact factor: 13.506

10.  A dynamic connection between centromeres and ND10 proteins.

Authors:  R D Everett; W C Earnshaw; A F Pluta; T Sternsdorf; A M Ainsztein; M Carmena; S Ruchaud; W L Hsu; A Orr
Journal:  J Cell Sci       Date:  1999-10       Impact factor: 5.285

View more
  13 in total

Review 1.  The long and winding road: human papillomavirus entry and subcellular trafficking.

Authors:  Michelle A Ozbun; Samuel K Campos
Journal:  Curr Opin Virol       Date:  2021-08-17       Impact factor: 7.121

2.  PML Body Component Sp100A Restricts Wild-Type Herpes Simplex Virus 1 Infection.

Authors:  Yilei Ma; Jingjing Li; Hongchang Dong; Zhaoxin Yang; Lingyue Zhou; Pei Xu
Journal:  J Virol       Date:  2022-03-30       Impact factor: 6.549

3.  Insights into the Role of Innate Immunity in Cervicovaginal Papillomavirus Infection from Studies Using Gene-Deficient Mice.

Authors:  Carolina Scagnolari; Fabiana Cannella; Alessandra Pierangeli; Rebecca Mellinger Pilgrim; Guido Antonelli; Dayana Rowley; Margaret Wong; Simon Best; Deyin Xing; Richard B S Roden; Raphael Viscidi
Journal:  J Virol       Date:  2020-06-01       Impact factor: 5.103

Review 4.  Rodent Papillomaviruses.

Authors:  Aayushi Uberoi; Paul F Lambert
Journal:  Viruses       Date:  2017-11-27       Impact factor: 5.048

Review 5.  Tripartite Motif 22 and Class II Transactivator Restriction Factors: Unveiling Their Concerted Action against Retroviruses.

Authors:  Greta Forlani; Roberto S Accolla
Journal:  Front Immunol       Date:  2017-10-18       Impact factor: 7.561

Review 6.  Targeted Gene Delivery Therapies for Cervical Cancer.

Authors:  Ángela Áyen; Yaiza Jiménez Martínez; Houria Boulaiz
Journal:  Cancers (Basel)       Date:  2020-05-21       Impact factor: 6.639

Review 7.  DAXX in cancer: phenomena, processes, mechanisms and regulation.

Authors:  Iqbal Mahmud; Daiqing Liao
Journal:  Nucleic Acids Res       Date:  2019-09-05       Impact factor: 16.971

8.  HPV E7-mediated NCAPH ectopic expression regulates the carcinogenesis of cervical carcinoma via PI3K/AKT/SGK pathway.

Authors:  Meng Wang; Xiaowen Qiao; Tamara Cooper; Wei Pan; Liang Liu; John Hayball; Jiaxiang Lin; Xiujie Cui; Yabin Zhou; Shule Zhang; Ying Zou; Ranran Zhang; Xiao Wang
Journal:  Cell Death Dis       Date:  2020-12-11       Impact factor: 8.469

Review 9.  CRISPR-Cas Targeting of Host Genes as an Antiviral Strategy.

Authors:  Shuliang Chen; Xiao Yu; Deyin Guo
Journal:  Viruses       Date:  2018-01-16       Impact factor: 5.048

Review 10.  Oncogenic human papillomaviruses.

Authors:  Alison A McBride
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-10-19       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.